Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.20 -0.13 (-1.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fennec Pharmaceuticals (FENC) Asset Writedowns and Impairment (2025)

Updated

Fennec Pharmaceuticals (FENC) reported Asset Writedowns and Impairment of $1.29 million for Q4 2025.

Analysis

Fennec Pharmaceuticals (FENC) Asset Writedowns and Impairment (2025) Analysis & Trends

For FY2025, Fennec Pharmaceuticals posted Asset Writedowns and Impairment of $773,000, up 49.5% from FY2024.

  • By year, Asset Writedowns and Impairment came in at $517,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Fennec Pharmaceuticals 357.35 Mn 238.66 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.29 Mn
API Access

Fennec Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=FENC&period=max&api_key=YOUR_API_KEY